View Mobile Friendly Conference List »

Julie Flygare, Patient Advocate, talks About Narcolepsy and Developing a Clinical Endpoint for FDA with DPharm Director, Valerie Bowling

Diagnosed with narcolepsy and cataplexy in 2007, award-winning author and founder of Project Sleep, Julie Flygare, shares her story and how she helped define a clinical endpoint with the FDA and what this can mean for the future of drug development.